Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-25

Clinical Trial Update: Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous methylnaltrexone for post-operative ileus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Post Operative Bowel Dysfunction | Phase 3 | Status: COMPLETED